TAFENOQUINE SUCCINATE

Search structure
Trade Names:
Synonyms:
Status: Approved (2018)
Entry Type: Small molecule
Molecule Category: Salt
UNII: DL5J0B8VSS
Parent Compound: TAFENOQUINE

Structure
InChI Key CQBKFGJRAOXYIP-UHFFFAOYSA-N
Smile COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1.O=C(O)CCC(=O)O
InChI
InChI=1S/C24H28F3N3O3.C4H6O4/c1-14-11-20(32-4)30-22-18(29-15(2)7-6-10-28)13-19(31-3)23(21(14)22)33-17-9-5-8-16(12-17)24(25,26)27;5-3(6)1-2-4(7)8/h5,8-9,11-13,15,29H,6-7,10,28H2,1-4H3;1-2H2,(H,5,6)(H,7,8)

Physicochemical Descriptors

Property Name Value
Molecular Formula C28H34F3N3O7
Molecular Weight 581.59
AlogP 5.91
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 9.0
Polar Surface Area 78.63
Molecular species BASE
Aromatic Rings 3.0
Heavy Atoms 33.0

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Malaria, Vivax 4 D016780 FDA

Related Entries

Scaffolds

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Psychiatric disorders
45.44
Nervous system disorders
21.95
General disorders and administration site conditions
8.47
Injury, poisoning and procedural complications
3.98
Ear and labyrinth disorders
3.72
Gastrointestinal disorders
3.08
Social circumstances
2.31

Cross References

Resources Reference
ChEMBL CHEMBL2364635
FDA SRS DL5J0B8VSS
PubChem 163761
SureChEMBL SCHEMBL1004186
CONTENTS